Evidence map›Paper›PMID 32447641›Full record

Observational studyClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer.

Y Zhao, N Yang, X Wang, Y Huang, X Zhou, D Zhang

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Y ZhaoDepartment of Breast Surgery, The Tumor Affiliated Hospital of Harbin Medical University, Harbin, China.
N YangDepartment of Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
X WangDepartment of In-Pantient Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Y HuangDepartment of Breast Surgery, The Tumor Affiliated Hospital of Harbin Medical University, Harbin, China.
X ZhouDepartment of In-Pantient Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
D ZhangDepartment of Surgery, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Harbin, 150086, Heilongjiang, China. mugong0@163.com.ORCID https://orcid.org/0000-0002-0983-8542
Harbin Medical University · CN

Funding

Harbin Science and Technology Bureau 2017RAXQJ067Heilongjiang science and technology planning project 201716
6 · The paper itself

Abstract

purposePatients presenting with lymphovascular space invasion (LVSI) had an absolute decrease in survival. In our present study, the potential roles of LVSI on tumor characteristics was explored to predict the difference in the prognosis of ER and HER2 positive T1 tumors.

methodsA total of 142 breast cancer patients diagnosed with ER+ and HER2+ tumors whose tumor size was ≤ 2 cm were included in this analysis. One hundred forty-two patients were divided into four groups, group 1 (lymph nodes+ and LVSI+), group 2 (lymph nodes+ and LVSI-), group 3 (lymph nodes- and LVSI+), group 4 (lymph nodes- and LVSI-). Univariate and multivariate Cox proportional hazard models were used to identify independent prognostic factors and calculate the HR and 95% CI. Kaplan-Meier and Cox regression models were used to test the prognostic significance.

resultsLVSI positivity was significantly associated with patient age, menopausal status, tumor size, lymph node status, Ki67, PR, and tumor grade. In the univariate and multivariate model, LVSI, PR, and Ki67 were significantly associated with DFS, and LVSI, lymph node status, PR, and Ki67 were significantly associated with OS. LVSI was significantly related to increased risk of DFS and OS only in the PR-negative and low-positive subgroups. It was a prognostic factor for DFS but not for OS in women with low Ki67 and was associated with DFS and OS in high-Ki67 tumors. Furthermore, patients who presented with only LVSI had a significantly worse survival rate than those with lymph node metastasis without LVSI in small tumors.

conclusionThe presence of LVSI was highlighted as a variable significant to survival. In further clinical practice, patients with LVSI may need more intensive treatment in certain populations.

Indexed as

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenAdultAgedAge FactorsBreast NeoplasmsCapillariesChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateKi-67 AntigenLymphatic MetastasisLymphatic VesselsMenopauseERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesKi-67 AntigenMKI67 protein, humanReceptors, EstrogenReceptors, ProgesteroneBreast cancerKi67LVSIPRSurvival

Identifiers

PMID32447641
OpenAlexW3026963123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.